BVS Bioventus Forecast, Technical & Fundamental Analysis
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions... Show more
BVS is expected to report earnings to rise 44.00% to 21 cents per share on August 11
Q2'26
Est.
$0.22
Q1'26
Beat
by $0.05
Q4'25
Beat
by $0.04
Q3'25
Beat
by $0.04
Q2'25
Est.
$0.21
The last earnings report on May 06 showed earnings per share of 15 cents, beating the estimate of 10 cents. With 180.81K shares outstanding, the current market capitalization sits at 595.51M.
A.I.dvisor indicates that over the last year, BVS has been loosely correlated with LIVN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BVS jumps, then LIVN could also see price increases.
The Moving Average Convergence Divergence (MACD) for BVS turned positive on June 16, 2026. Looking at past instances where BVS's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BVS's RSI Indicator exited the oversold zone, of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BVS advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .
BVS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on June 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BVS as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
BVS moved below its 50-day moving average on May 21, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BVS crossed bearishly below the 50-day moving average on May 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BVS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for BVS entered a downward trend on June 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BVS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.153) is normal, around the industry mean (10.753). P/E Ratio (21.439) is within average values for comparable stocks, (61.509). Projected Growth (PEG Ratio) (1.134) is also within normal values, averaging (3.702). BVS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (1.066) is also within normal values, averaging (23.786).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BVS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
